Effects of RNA degradation on gene expression analysis of human postmortem tissues FASEB J. Lee et al.
10.1096/fj.04-3552fje
Supplemental Data
Files in this Data Supplement:
Commercial RNA
-
(CommercialRNA.xls; 17 KB) A list of human total RNA obtained from commercial sources to augment the Body Index. Information includes donor's gender and age, vendor source, and pathology, if available.
Donor Information
-
(DonorInformation.xls; 25 KB) Donor information for the 3 male and 1 female bodies used in the study, including gender, age, race, medical history and cause of death, and list of tissues obtained from each donor.
Rat 230A labile probesets
-
(Rat230Alabileprobesets.xls; 36 KB) A list of probesets identified to be labile (i.e. they appear to be more susceptible to degradation) from the rat duodenum RNA degradation experiment using the RAE230A array.
Thymus-specific gene list
-
(Thymusspecificgenelist.xls; 31 KB) Description: The full list of transcripts (129) that have been identified to be at least 8-fold higher in expression in the thymus samples compared to the rest of the Body Index tissues.
Actin GAPDH Fig.7 GeneChip data
-
(actinGAPDHFig.7GeneChipdata.xls; 82 KB) Description: Human U133 Plus 2.0 GeneChip data for actin, GAPDH, and genes listed on Figure 7.
Rat duodenum GeneChip data
-
( RatduodenumGeneChipdata.zip; 4.5 MB zipped, 16 MB unzipped) The entire RAE230A GeneChip data from the rat duodenum experiment. Signal intensity values are RMA-normalized and GCOS present/absent calls are included as well.
